RADXRadiopharm Theranostics, LtdRunning, no new patients
Phase 2b Imaging Study of RAD101 in Participants With Suspected Recurrent Brain Metastases
Brain Metastases From Solid Tumors
0Calmworry score, out of 100
No strong warning signs right now. The score counts warning signs; it is not a prediction.
Why this score
No warning signs right now. That's why the score is 0.
Score over time
- Stage
- Phase 2
- Patients
- 30 (planned)
- Started
- Dec 13, 2024
- Main results expected
- Apr 23, 2026
- Fully finished
- Oct 2026
- Results posted
- not yet
What counts as success
The trial's main goal(s), called the “primary outcome.”
Concordance between RAD101 PET/MRI and MRI with macrocyclic gadolinium
Measured over: 1 Week
Concordance between RAD101 PET/MRI and MRI with macrocyclic gadolinium
Measured over: 1 Week
Concordance between RAD101 PET/MRI and MRI with macrocyclic gadolinium
Measured over: 1 Week
Changes Tremor has spotted
No changes since Tremor started watching this trial.
Show details (technical version)
Score inputs
- none
Raw record changes
- none yet
Trial ID NCT06777433 · record last updated 2026-08-12 · checked 2026-11-09 15:47 UTC